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Abstract
Background:  Cortactin activates the actin-related 2/3 (Arp2/3) complex promoting actin
polymerization to remodel cell architecture in multiple processes (e.g. cell migration, membrane
trafficking, invadopodia formation etc.). Moreover, it was called the Achilles' heel of the actin
cytoskeleton because many pathogens hijack signals that converge on this oncogenic scaffolding
protein. Cortactin is able to modulate N-WASP activation in vitro in a phosphorylation-dependent
fashion. Thus Erk-phosphorylated cortactin is efficient in activating N-WASP through its SH3
domain, while Src-phosphorylated cortactin is not. This could represent a switch on/off mechanism
controlling the coordinated action of both nucleator promoting factors (NPFs). Pedestal formation
by enteropathogenic Escherichia coli (EPEC) requires N-WASP activation. N-WASP is recruited by
the cell adapter Nck which binds a major tyrosine-phosphorylated site of a bacterial injected
effector, Tir (translocated intimin receptor). Tir-Nck-N-WASP axis defines the current major
pathway to actin polymerization on pedestals. In addition, it was recently reported that EPEC
induces tyrosine phosphorylation of cortactin.
Results: Here we demonstrate that cortactin phosphorylation is absent on N-WASP deficient
cells, but is recovered by re-expression of N-WASP. We used purified recombinant cortactin and
Tir proteins to demonstrate a direct interaction of both that promoted Arp2/3 complex-mediated
actin polymerization in vitro, independently of cortactin phosphorylation.
Conclusion: We propose that cortactin binds Tir through its N-terminal part in a tyrosine and
serine phosphorylation independent manner while SH3 domain binding and activation of N-WASP
is regulated by tyrosine and serine mediated phosphorylation of cortactin. Therefore cortactin
could act on Tir-Nck-N-WASP pathway and control a possible cycling activity of N-WASP
underlying pedestal formation.
Background
Enteropathogenic Escherichia coli (EPEC) are an important
cause of infantile diarrhea, especially in developing coun-
tries. EPEC adhere, and cause the local effacement of the
microvilli of intestinal epithelial cells, giving raise to so-
called attaching and effacing (A/E) lesions. In vitro, EPEC
attach to infected cells by forming pedestal-like structures
enriched in polymerized actin and other host cell proteins
[1]. The type III secretion system delivers into host cells
the translocated intimin receptor (Tir), which is inserted
into the cell plasma membrane such that a loop is
exposed on the cell surface that binds to another bacterial
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protein, the adhesin intimin [2]. This binding induces the
clustering of Tir, followed by its phosphorylation on tyro-
sine residue 474 in the cytoplasmic C-terminal domain.
The phosphotyrosine moiety recruits the host cell adaptor
protein Nck [3], which binds and presumably activates N-
WASP, leading to actin polymerization mediated by the
Arp2/3 complex [4]. Although this pathway is recognized
as the principal one operating in EPEC, another Nck-inde-
pendent pathway has also been described in these bacteria
[5]. Furthermore, the complexity of EPEC signal transduc-
tion is not fully understood [6].
Tir is inserted in the cell membrane, where it adopts a
hairpin-loop structure, with both N and C termini project-
ing into the host cytoplasm [2]. Pedestals are dynamic
structures that undergo constant remodeling by cycles of
actin polymerization/depolymerization [7]. It is impor-
tant to understand the contribution of other signals to
pedestal formation, not only for EPEC but also for other
actin-based processes. For instance, it has been postulated
that Tir-Nck signaling mimics the nephrin-Nck-actin
pathway [8].
Cortactin is a key regulator of the actin cytoskeleton which
plays a crucial role in cell invasion [9] and actin-based
motility during the infection of many microbial patho-
gens [10]. Cortactin possesses an N-terminal acidic
domain (NTA) which harbors a DDW motif that activates,
albeit weakly, the Arp2/3 complex at branching points
[11,12]. The NTA domain is followed by a series of repeat
domains that bind filamentous actin (F-actin). The C-ter-
minal SH3 domain of cortactin [13] binds various pro-
teins, such as N-WASP [14], which is a ubiquitously
expressed member of the WASP (Wiskott-Aldrich Syn-
drome) family of proteins. Cortactin can be phosphor-
ylated by tyrosine kinases (Src, Fer, Syk and Abl) and
serine/threonine kinases (Erk and Pak) [15]. Src kinase
targets tyrosine residues 421, 466 and 482 while Erk phos-
phorylates serines 405 and 418 [16] which lie in a proline-
rich area. Interestingly, a Src family member (Fyn) [17]
and Abl kinases phosphorylate Tir [18].
The Arp2/3 complex can be independently activated to
initiate actin polymerization by the VCA (Verprolin Cofi-
lin Acidic) domain of WASP members and by both the
NTA and F-actin-binding repeats of cortactin. Theoreti-
cally N-WASP, cortactin and the Arp2/3 complex can form
ternary complexes [19]. Cortactin has been shown in vitro
to bind and activate N-WASP via an SH3 proline-rich
domain interaction [14]. This activation is regulated pos-
itively and negatively when cortactin is phosphorylated by
Erk and Src respectively. Erk phosphorylation of cortactin
or the double mutation S405,418D in cortactin that mim-
ics this phosphorylation enhance the protein's binding to
and activation of N-WASP. Conversely, Src phosphoryla-
tion inhibits the ability of both Erk-phosphorylated cort-
actin, and that doubly mutated S405,418D cortactin, to
activate N-WASP. Furthermore, phospho-mimetic muta-
tion of the three tyrosine residues targeted by Src (Y421,
Y466, and Y482) inhibited the ability of S405,418D cort-
actin to activate N-WASP. These results led us to hypothe-
size that Erk phosphorylation liberates the SH3 domain of
cortactin from intramolecular interactions, allowing it to
synergize with N-WASP in activating the Arp2/3 complex,
and that Src phosphorylation terminates cortactin activa-
tion of N-WASP. This proposed on/off switching mecha-
nism suggests that phosphorylation of cortactin regulates
the accessibility and/or affinity of its SH3 domain towards
its targets. 'S/Y model' may be relevant for actin dynamics
in multiple cell processes [15] and it may partially explain
the coordinated action of cortactin and N-WASP proteins,
therefore connecting the two major families of Arp2/3
complex activators. Consistent with this model, recent
structural data showed that cortactin adopts a 'closed'
globular conformation in which its SH3 domain interacts
with the actin-binding repeats [20].
This model has opened up new directions for studies in
many cell systems. For example, serine phosphorylation
of cortactin has been proposed to be relevant for actin
polymerization, while tyrosine phosphorylation have
been shown to selectively control adhesion turnover [21].
This suggests that different phosphocortactin forms par-
ticipate in distinct signaling pathways.
Although it is clear that cortactin participates in pedestal
actin dynamics, the underlying mechanism is not well
understood. Previous studies have shown that cortactin
translocates to EPEC pedestals. Over-expression of trun-
cated forms of cortactin blocks pedestal formation [22]. A
follow-up study to this work focused on the role of cortac-
tin domains and Erk/Src phosphorylation, and it con-
firmed that truncated forms of cortactin exert a dominant
negative effect in pedestal formation by EPEC and EHEC
(Enterohemorrhagic Escherichia coli). This study suggests
that cortactin is recruited through its α-helical region, and
the authors conclude that tyrosine phosphorylation is rel-
evant to pedestal formation, whereas serine phosphoryla-
tion seems to have no effect on actin assembly underneath
the bacteria [23]. However, this conclusion is based exclu-
sively on experiments with phosphorylation-mimicking
mutants, without any comparison with the corresponding
non-phosphorylatable counterparts.
Nck is not involved in N-WASP recruitment by EHEC.
Instead, the EspFu/Tccp effector activates N-WASP,
thereby mimicking Cdc42 signaling [24,25]. Cantarelli et
al. have proposed cortactin as the 'missing link' connect-
ing TirEHEC and EspFu/Tccp [26]. They showed that EHEC
initially induces tyrosine phosphorylation of cortactinCell Communication and Signaling 2009, 7:11 http://www.biosignaling.com/content/7/1/11
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and then induces its dephosphorylation, similarly to the
transient cortactin phosphorylation during Helicobacter
pylori infection [27]. However, using the two-hybrid sys-
tem, they reported that tyrosine-phosphorylated cortactin
binds both TirEHEC and EspFu/Tccp, and consistent with
previously described binding assays using recombinant
purified proteins [14], only Erk-phosphorylated cortactin
binds N-WASP. Recent in vitro studies using cells deficient
in N-WASP suggest that cortactin recruitment to EHEC
pedestals occurs downstream of EspFu/Tccp and N-WASP
[28]. It is therefore necessary to gain further insights into
cortactin function in both systems. Major unresolved
questions include whether cortactin and TirEPEC interact
directly, whether cortactin participates in the Tir-Nck-N-
WASP pathway, and how cortactin binding partners mod-
ulate its nucleating activity on pedestals. Thus, deepening
our understanding of the involvement of cortactin on
pedestals dynamics is relevant for many reasons.
Results
Role of cortactin motifs in pedestal formation
Reduction of cortactin expression by siRNA or over-
expression of its isolated SH3 domain, polyproline region
or its α-helical region resulted in a drastic decrease in
actin-pedestal formation during infection with EPEC [23].
However the role of cortactin's Arp2/3 binding and acti-
vating region has not been addressed [23]. Therefore, we
investigated its contribution to actin assembly on pedes-
tals using EPEC to infect HeLa cells transiently transfected
with GFP-cortactin. Pedestals were visualized by immun-
ofluorescent staining of actin using fluorescent phalloidin
and bacteria with DAPI. As previously reported [23], no
differences on the number of attached bacteria were
observed for the transfectants used (data not shown).
The cortactin NTA domain carries a 20DDW22 motif that
binds and activates the Arp2/3 complex. Mutation of this
motif to 20DDA22, hereafter referred to as W22A, abol-
ished this activity [11]. To determine whether this motif is
necessary for pedestal formation we transfected HeLa cells
with GFP-W22A. We used wild-type (WT) cortactin (GFP-
FL) and GFP alone as controls. As shown in Fig. 1, over-
expression of GFP-FL cortactin allowed pedestal forma-
tion to levels similar to those in cells expressing GFP. Fig.
1C (black bars) shows normalized percentages and stand-
ard deviations for GFP-FL. Results of three independent
experiments were considered statistically significant (p <
0.01 by Student's t-test). Since the constructs bear a GFP-
tag we were able to simultaneously assess the localization
of different cortactin forms (Fig. 1A, B and 1C). We
observed GFP-FL cortactin to localize in 70% of pedestals,
compared to 4% for GFP-transfected cells (open bars).
Importantly, the number of pedestals in cells expressing
GFP-W22A mutant was significantly lower than in GFP-FL
transfected cells (51% vs 83%). This result indicates that
cortactin W22A exerts a dominant negative effect, which
may mean that cortactin binding and activation of the
Arp2/3 complex is necessary for pedestal formation.
Cortactin has a C-terminal SH3 domain that binds several
proteins. Mutation of a critical amino acid (W525K) abol-
ishes its binding to known targets [29] such as N-WASP
[14]. We used this mutant to assess the contribution of the
cortactin SH3 domain to pedestal formation; we found
that its expression inhibits pedestal formation to an even
greater extent than the W22A mutant (31% vs 51%). This
indicates that cortactin W525K mutant exerts a dominant-
negative effect, corroborating previous results [23]. In pre-
vious work, we described that the cortactin SH3 domain is
able to activate N-WASP and we proposed a model for the
regulation of N-WASP activation by cortactin, in which
cortactin is switched on by Erk phosphorylation of serines
405 and 418, while it is switched off by Src phosphoryla-
tion of tyrosines 421, 466 and 482 [14]. Next we repeated
the pedestal formation assay with cells expressing the cort-
actin S405,418D double mutant, which mimics Erk phos-
phorylation and activates N-WASP in vitro, as well as its
non-phosphorylatable counterpart (S405,418A). The
S405,418D mutant allowed pedestal formation to a simi-
lar extent as the WT cortactin (90%) and to a greater
extent, although not significantly greater, than the GFP
negative control (83%). The phosphoserine-mimicking
cortactin mutant accumulated in only 21% of pedestals
and showed a weak, diffuse pattern of localization in the
cytoplasm and pronounced staining in the nucleus. In
contrast, the mutant that abolished Erk phosphorylation
(S405,418A) impaired pedestal formation (34%) and its
own translocation to them (3%). These results suggest
that Erk phosphorylation of cortactin contributes to ped-
estals formation.
Similarly, we wanted to address the role of Src-mediated
phosphorylation of cortactin. We therefore used the phos-
photyrosine-mimicking mutant (Y421,466,482D) and
the phosphotyrosine deficient mutant (Y421,466,482F).
In both cases pedestal formation and location of these
constructs on them were impaired (33%/7%; 28%/14%,
Fig. 1B and 1C). These results indicate that Src-mediated
phoshorylation of cortactin seems to inhibit pedestal for-
mation and that a dynamic phosphorylation of these tyro-
sine residues play a role in the formation of pedestals.
Total F-actin content of cells transfected with different 
cortactin mutants
Although no appreciable changes in the cellular architec-
ture were observed, we wanted to exclude the possibility
that over-expression of cortactin mutants induces a gen-
eral alteration of the actin cytoskeleton. We therefore used
flow cytometry to assess the total basal F-actin content of
the different transfectants. Fig. 1C (grey bars) and 1DCell Communication and Signaling 2009, 7:11 http://www.biosignaling.com/content/7/1/11
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Effect of the overexpression of WT and cortactin mutants on pedestal formation and total actin content Figure 1 (see previous page)
Effect of the overexpression of WT and cortactin mutants on pedestal formation and total actin content. (A) 
Schematic of cortactin domains and mutants under investigation. (B) Cortactin mutants block pedestal formation. Immunofluo-
rescence images of HeLa cells transfected with WT (FL) and cortactin mutants and infected with EPEC for three hours. 
Mutants used are: Arp2/3 activation mutant (W22A), Erk-phosphorylation-mimicking mutant S405,418D (SD), Erk non-phos-
phorylatable mutant S405,418A (2A), Src-phosphorylation-mimicking mutant Y421,466,482D (3D), Src non-phosphorylatable 
mutant Y421,466,482F (3F) and SH3 domain mutant (W525K). GFP staining is shown in green, F-actin is in red, and bacteria 
and nuclei are in blue. The last column shows merged images of GFP and actin staining. Pictures are at 600× magnification. 
Scale bar 10 μm. (C) Quantification of pedestal number, cortactin localization and total F-actin content of transfectants. Black 
bars represent percentages normalized to WT of pedestal formed after 3 hours of infection of HeLa cells expressing GFP-FL 
and cortactin mutants. White bars represent normalized percentages of localization to pedestals. Grey bars represent the 
mean fluorescence of total actin content determined by flow cytometry. Experiments were performed at least three times with 
similar results. (D) Total actin content of HeLa cells transfected with WT and cortactin mutants. Histogram charts of HeLa 
cells expressing WT and cortactin mutants. Cells were permeabilized and stained with TRITC-phalloidin and total F-actin con-
tent was analyzed by flow cytometry. Overlaid histograms show the actin content of cortactin/mutants with respect to GFP 
transfected control cells (green curve). Pretreatment with cytochalasin D (blue curve) of cells expressing WT cortactin is 
shown as a control.
EPEC-induced tyrosine phosphorylation of cortactin depends on N-WASP Figure 2
EPEC-induced tyrosine phosphorylation of cortactin depends on N-WASP. (A) Tyrosine phosphorylation of cortac-
tin occurs in WT but not in N-WASP-deficient MEFs. WT, N-WASP-deficient and N-WASP reconstituted cells were infected 
with EPEC for three hours. The level of tyrosine phosphorylation of cortactin was assessed by Western blotting using an anti-
body against phospho-Y466 cortactin (upper panel). The same membrane was stripped and reprobed with anti-cortactin mon-
oclonal antibody 4F11. N-WASP Western blotting was also performed to confirm the genotype of the MEFs. Actin was used as 
a loading control. Similar results were obtained in at least three independent experiments. (B) EPEC infection activates Src to 
similar extends in WT, N-WASP-deficient and R cells. WT, N-WASP-deficient and N-WASP reconstituted cells were infected 
with EPEC for three hours and analyzed for Src activation (phospho-Y416 Src) (upper panel). Medium and lower panels 
showed Src and actin blots, respectively. (C) Pervanadate treatment induces a robust phosphorylation of cortactin on tyrosine 
466 in WT, N-WASP-deficient and R cells. Lysates of vehicle (DMSO)-treated MEFs and lysates of pervanadate-treated MEFs 
(diluted 1/500 *) were subjected to SDS-PAGE and Western blotted with antibody against phospho-Y466 cortactin. A second 
gel was loaded in parallel with the same amount of protein for both types of lysates and blotted for cortactin and actin for pro-
tein and loading controls, respectively (medium and lower panels). (D) EPEC infection induces Erk1/2 activation in WT but not 
N-WASP-deficient MEFs. WT, N-WASP-deficient and R cells were infected with EPEC for three hours. The level of Erk activa-
tion was assessed by Western blotting using a mAb specific for activated Erk phosphorylated on Thr202 and Tyr204 (upper 
panel). Medium and lower panels show Erk and actin blots for Erk protein and loading control respectively. Experiments were 
performed at least three times.Cell Communication and Signaling 2009, 7:11 http://www.biosignaling.com/content/7/1/11
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show the mean fluorescence of GFP transfectants, which
did not significantly differ based on Student's t-test. As a
control, transfected cell were pretreated with Cytochalasin
D, a drug known to inhibit actin polymerization (Fig. 1D,
bottom right panel). In addition, this experiment allowed
us to calculate the transfection efficiency, which was esti-
mated as 60–70%, based on the analysis of the expression
of GFP constructs (data not shown).
EPEC induces N-WASP-dependent tyrosine 
phosphorylation of cortactin
Contrary to the transient phosphorylation induced by
EHEC, EPEC infection of CH7 mouse fibroblasts induces
tyrosine phosphorylation of cortactin [26]. Src has been
shown to phosphorylate cortactin on tyrosines Y421, 466
and 482 [30], which decreases cortactin affinity for N-
WASP in vitro [14]. In addition, N-WASP-deficient cells do
not form pedestals [31]. These observations prompted us
to examine the phosphorylation status of cortactin in WT
mouse embryonic fibroblasts (MEFs), MEFs deficient in
N-WASP and MEFs deficient in N-WASP in which the pro-
tein was later restored through retroviral transduction
(rescued, R). First, we performed Western blotting control
experiments to assess the expression of N-WASP, cortactin
and actin (Fig. 2A).
Fig. 2A shows that EPEC induces phosphorylation of tyro-
sine 466 at 3 hours of infection in WT MEFs, as detected
using an antibody against phospho-Y466-cortactin. This
result was corroborated using a second phospho-specific
antibody (pY421, data not shown). Unexpectedly, phos-
phorylation of tyrosine residue 466 was not induced in N-
WASP-deficient cells. This result suggests that tyrosine
phosphorylation of cortactin during EPEC infection
depends on the presence of N-WASP. To verify this, we
infected R cells with EPEC and examined levels of
phosphoY466-cortactin. Fig. 2A shows that N-WASP re-
expression partially restored cortactin tyrosine phosphor-
ylation levels. In three independent experiments the nor-
malized average induction was 1 ± 0.2 for WT cells, 0 for
N-WASP-deficient cells and 0.5 ± 0.1 for R cells. This sup-
ports the idea that EPEC-induced tyrosine phosphoryla-
tion of cortactin in cells requires N-WASP.
Given the absence of cortactin tyrosine phosphorylation
in EPEC-infected N-WASP-deficient cells, we then checked
Src activation, using a commercially available phospho-
active Src antibody (pY416). Fig. 2B demonstrated that
equal activation of Src was achieved during EPEC infec-
tion in all cell types studied, while, as expected, the levels
of total Src remained constant during infection. This result
showed that the lack of cortactin phosphorylation in N-
WASP-deficient cells was not due to a block in Src activa-
tion. As a further control, we treated the cells with per-
vanadate and observed robust phosphorylation of
cortactin tyrosine 466 (Fig. 2C, upper panel).
Similarly we sought to establish the activation status of
Erk in EPEC-infected cells. We used a phospho-specific
monoclonal antibody that detects the activated form of
Erk1/2 (anti pThr202-pTyr204). EPEC induced the activa-
tion of Erk on WT MEFs (Fig. 2D first lane), in agreement
with a previous report on T84 epithelial cells [32]. How-
ever, infection of N-WASP-deficient cells showed reduced
activation of Erk which was recovered in R cells. This
result implies that Erk is activated by EPEC and may phos-
phorylate cortactin in vivo. More importantly, N-WASP is
absolutely required for the induction of Erk activation at
3 hours of infection. However, WT MEFs treated with ERK
inhibitors PD98056 or U0126 showed no difference in
the number of pedestals formed ([23] and data not
shown).
Tir binds cortactin and induces the latter to nucleate actin 
in vitro through an Arp2/3 complex-mediated pathway
The bacterial protein called Tir initiates what is considered
to be the principal signaling cascade, which consists of Tir
clustering and concomitant phosphorylation on its tyro-
sine 474, which then recruits Nck. The latter presumably
binds N-WASP to initiate Arp2/3 complex-mediated actin
polymerization [1]. We wanted to gain insights into how
cortactin functions in pedestal signaling. Our initial
hypothesis was that cortactin and Tir interact directly.
Therefore we used the Scansite database [33] to search for
motifs in the Tir sequence to which cortactin SH3 domain
could bind. We found a consensus motif (NNSIPPAPPLP-
SOTD) centered on proline 20 of Tir.
We first performed pull-down experiments with purified
recombinant Tir [34] and cortactin proteins (Fig. 3). We
produced WT GST-Tir that was purified using GSH beads
and treated with PreScission enzyme, which excised Tir
and at the same time removed the GST tag (Fig. 3,
Coomassie gel). This Tir protein was used as the input in
pull-down experiments with GST-cortactin. The first line
of Fig. 3A shows that cortactin binds Tir in vitro.
To map the domains involved in the interaction, we per-
formed pull-down experiments using cortactin mutants as
follows: full-length W525K (mutated SH3 domain), the
N-terminus (NH2, residues 1–333), and the isolated SH3
domain (SH3, residues 458–546). GST was used as a neg-
ative control. In agreement with our initial hypothesis, the
isolated SH3 domain of cortactin bound Tir. However, the
N-terminal domain of cortactin also bound Tir (Fig. 3A,
third line). This unforeseen interaction was confirmed in
experiments with cortactin carrying the point mutation,
W525K in the SH3 domain (Fig. 3A). We obtained similar
results using as input the Tir phospho-mimicking mutantCell Communication and Signaling 2009, 7:11 http://www.biosignaling.com/content/7/1/11
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TirY474D (TirD, data not shown). Next we tested the cort-
actin S405,418D (SD) and Y421,466,482D (3D) mutants
which were similar to the WT form in their ability to bind
both Tir (Fig. 3B) and TirD (data not shown). These
results demonstrate that cortactin and Tir interact directly
in vitro, that this interaction involves both the N-terminal
part and the SH3 domain, and that it appears to be inde-
pendent of cortactin phosphorylation.
Given the direct interaction between Tir and cortactin, we
wondered whether Tir can activate the ability of cortactin
to promote Arp2/3-mediated actin polymerization. We
coupled recombinant Tir protein (or TirD, data not
shown) to 1 μm beads, and then we washed the beads
with Xb buffer and blocked them in Xb buffer containing
1% BSA. Next we incubated them with purified Arp and
actin in Xb buffer containing WT and cortactin mutants.
Fig. 3C shows that Tir activated WT cortactin and both SD
and 3D mutants. Similar results were obtained for TirD
(data not shown). The W525K mutant was also activated,
although weakly. As expected, W22A cortactin was not
activated, indicating that the effect was mediated by cort-
actin activation of the Arp2/3 complex. As a negative con-
trol we used naked beads that showed no activation.
Conversely, experiments in which cortactin and its
mutants were coupled to GSH beads showed similar
results (data not shown). These results indicate that Tir
activates the ability of cortactin to promote Arp2/3-medi-
ated actin polymerization in vitro.
Tir binds cortactin and promotes its activation of Arp2/3-mediated actin polymerization Figure 3
Tir binds cortactin and promotes its activation of Arp2/3-mediated actin polymerization. (A) Cortactin binds Tir 
through the N-terminal and the SH3 domains in vitro. Recombinant Tir was incubated with WT cortactin (FL) and with the 
three mutants expressed as GST fusion proteins: the SH3 domain mutant (W525K), the N-terminal (NH2) domain and the 
SH3 domain (SH3). GST alone served as a negative control. The pull-downs were subjected to SDS-PAGE and blotted with 
anti-Tir monoclonal antibody. In the last line, one-fifth of the total amount of Tir that was used as input per pull-down sample 
(upper left panel). Coomassie staining of proteins is also shown (lower panels). Half of the GST-proteins and on-fifth of Tir that 
was used in the pull-downs was stained with Coomassie blue. (B) Cortactin binds Tir independently of phosphorylation in vitro. 
Recombinant Tir was incubated with WT cortactin (FL) and with the three mutants expressed as GST fusion proteins: Arp2/3 
domain mutant (W22A), Erk-phosphorylation-mimicking mutant (SD) and Src-phosphorylation- mimicking mutant (3D). GST 
alone served as a negative control (right upper panel). Coomassie staining of proteins is also shown (lower panels). Half of the 
GST-proteins and one-fifth of Tir that were used in the pull-downs were stained with Coomassie blue (shown in A). (C) 
Immunofluorescence images of Tir-coupled beads incubated with actin, Arp2/3 and cortactin/mutants. Carboxilate beads 
(diameter 1 μm) uncoupled (left panels) or coupled to Tir protein (right panels) were incubated with a solution of 500 nM WT 
cortactin or cortactin mutants proteins for 1 hour. Then, actin and Arp were added and incubated at RT to allow actin polym-
erization. After 1 hour TRITC-phalloidin was added, and the samples were observed immediately on a microscope. Pictures 
were taken at 600× magnification. Scale bar 40 μm.Cell Communication and Signaling 2009, 7:11 http://www.biosignaling.com/content/7/1/11
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Cortactin binding to Tir in N-WASP-deficient cells infected 
by EPEC
Because cortactin binds directly both Tir (Fig. 3) and N-
WASP [14], we analyze cortactin-Tir interaction in N-
WASP-deficient cells. Since those cells do not form pedes-
tals [35], we wondered if Tir would be present at similar
levels to WT cells. To address this question, we used a pre-
viously described fractionation protocol that enriches in
Tir-containing membranes ([36] and Materials and Meth-
ods). As shown in Fig. 4A, as expected Tir was enriched in
the pellets compared to supernatants, as detected by west-
ern-blotting with anti-Tir mAb. We observed that a band
with slower electrophoretic motility was the predominant
form of Tir in the pellets, which represents fully-modified
Tir [37]. WT and N-WASP-deficient cells presented detect-
able amounts of mature Tir that was slightly reduced on R
cells.
FL cortactin has a closed conformation [14,20]. Therefore,
we decided to use N-terminal cortactin (NH2), the SH3
domain (SH3) and GST as a negative control to perform
pull-down experiments with lysates of EPEC infected and
uninfected WT, N-WASP-deficient and R cells. Western
blotting in Fig. 4B shows that NH2 bound Tir in EPEC
infected but not uninfected cells, with no appreciable dif-
ferences between WT, N-WASP and R cells. Similar results
were obtained with total cell lysates although longer expo-
sure times where necessary to detect Tir (data not shown).
In contrast, neither the isolated SH3 domain nor the GST
negative control bound Tir in any of the cells types used.
In view of these results, we can conclude that in cells, cort-
actin binds Tir primarily through its N-terminal region. To
test whether the SH3 domain of cortactin prefers to bind
N-WASP over Tir, we performed pull-downs with clarified
total lysates, and we then stripped and reprobed the blots
with anti-N-WASP antibody. This approach was necessary
because the pellets did not contain easily detectable levels
of N-WASP (data not shown). As previously described
[14], the SH3 domain of cortactin was able to pull-down
N-WASP in WT cells but not N-WASP-deficient cells (data
not shown). This argues in favor of the conclusion that the
N-terminal region of cortactin is involved in binding Tir,
while the SH3 domain is involved in binding N-WASP.
Cortactin binding to Tir in N-WASP-deficient cells infected by EPEC Figure 4
Cortactin binding to Tir in N-WASP-deficient cells infected by EPEC. (A) Tir is abundant in membrane-enriched 
fractions. EPEC-infected and uninfected P100 monolayers of WT, N-WASP-deficient, and R MEFs were lysed in imidazole 
buffer, fractionated, subjected to SDS-PAGE and blotted with anti-Tir mAb. As previously described, Tir appears as a doublet 
whose upper band is enriched in the membrane fractions (pellets). The signal from the anti-actin antibody is shown as a loading 
control. (B) Cortactin binds Tir in cells through its N-terminal domain. Cell lysates of uninfected and EPEC- infected WT, N-
WASP-deficient, and R (R) MEFs were analyzed in pull-down experiments using GST fusion proteins as follows: cortactin N-
terminal truncation mutant (NH2), the isolated SH3 domain (SH3), and GST alone. Western blotting with anti-Tir monoclonal 
antibody revealed a unique band corresponding to the slower-moving band. This band was present only in the NH2 pull-down 
conducted on all three types of lysates. These experiments were performed at least three times.Cell Communication and Signaling 2009, 7:11 http://www.biosignaling.com/content/7/1/11
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Discussion
Cortactin is a scaffold protein implicated in many cellular
processes since it directly contributes to cytoskeleton
remodeling. Cortactin also has oncogenic properties due
to its role in controlling invadopodia formation and cell
migration. Moreover, cortactin has emerged as an impor-
tant target of numerous pathogens, including enteropath-
ogenic E. coli that manipulate the actin cytoskeleton in
order to invade the host and propagate there [10]. EPEC
cause severe diarrheal disease in humans by colonizing
the gut mucosa and producing A/E lesions. EPEC attach to
mammalian intestinal cells and induce reorganization of
the actin cytoskeleton into 'pedestal-like' structures under-
neath the bacteria. A crucial event for pedestal formation
is the insertion into the host-cell membranes of the EPEC
effector Tir, which is initially injected into the cell by a
type III secretion system. Tir mimics signaling pathways of
the infected cell. Thus it can serve as a powerful model sys-
tem to study eukaryotic transmembrane signaling [38]. In
fact, the Tir-Nck-N-WASP pathway is the principal one
through which actin polymerizes in EPEC pedestals.
Those reasons prompted us to study cortactin signaling
during EPEC infection using N-WASP-deficient cells.
Although cortactin localizes to pedestals and its truncated
forms exert a dominant negative effect, its function is not
clear. For example, does cortactin on its own contribute to
actin polymerization in pedestals? Our transfection exper-
iments with the GFP-W22A cortactin point mutant dem-
onstrate that cortactin binding and activation of the Arp2/
3 complex is necessary for pedestal formation, which sug-
gests that cortactin indeed contributes to efficient actin
polymerization. A complementary study used a similar
approach to examine the role of cortactin domains on
pedestal formation [23]. It reported identical results to
ours regarding WT cortactin and the mutant W525K.
However, the W22A mutant was not studied in that work.
To address the role of Erk and Src phosphorylation of cort-
actin, we used both phosphorylation-mimicking and
non-phosphorylatable mutants; previous studies have
used only the former [23]. Therefore, we were able to
detect a 'neutral' effect on pedestal formation of mutant
that mimics phosphorylation by Erk, while the Erk non-
phosphorylatable form blocked pedestal formation. Thus,
we conclude that phosphorylation of cortactin by Erk may
positively regulate pedestal formation. Our conclusion is
also supported by other studies: over-expression of a
mutant of cortactin mimicking phosphorylation on serine
enhanced invadopodia formation in cells in which endog-
enous cortactin expression had previously been reduced
by siRNA [39]. We could not use a similar approach in the
present study because the cells detached and died upon
EPEC infection (data not shown). The presence of endog-
enous cortactin may explain why the SD mutant did not
lead to significantly more pedestals than WT, although an
increase was detectable. Experiments with cortactin-defi-
cient cells may provide the definitive answer to this ques-
tion. In contrast, phosphoserine-mimicking cortactin
accumulated in only one-fourth of pedestals and showed
weak diffuse staining in the cytoplasm and a strong
nuclear staining. We do not understand this distribution,
and we are currently investigating it.
Src phosphorylates cortactin on positions Y421, 466, and
482 [30]. Therefore we used phosphorylation-mimicking
and non-phosphorylatable triple mutants. In both cases
pedestal formation was impaired, as well as the accumu-
lation of the mutant proteins to the pedestals that did
form. These results indicate that phoshorylation of cortac-
tin by Src inhibits pedestal formation. The same conclu-
sion was reached using the double Y421,466D mutant
which partially mimics Src phosphorylation [23], which
further supports the idea that cortactin phosphorylated on
tyrosine inhibits pedestal formation. The fact that both Src
mimicking and non-phosphorylatable cortactin forms
inhibited the formation of pedestals might indicate that a
dynamic phosphorylation of these tyrosine residues play
a role in the formation of pedestals (Fig. 5). Finally, we
can exclude that the effects on pedestals were due to
changes in the total actin content of the transfectants,
because the content was similar for all transfectants exam-
ined (Fig. 1). This argues that our results on pedestal for-
mation reflect the specific effects of phosphorylation or
lack of phosphorylation.
A crucial finding of this study is that tyrosine phosphor-
ylation of cortactin is abrogated in N-WASP-deficient cells
but recovered by N-WASP re-expression (Fig. 2). In agree-
ment with these results, preliminary data using an anti-
body against cortactin phosphorylated on serine 405
show that EPEC induces serine phosphorylation of cortac-
tin, which is not up-regulated in EPEC infected N-WASP-
deficient cells (Narcisa Martínez-Quiles and Steffen Back-
ert, unpublished results). Importantly, the lack of cortac-
tin tyrosine phosphorylation was not due to a defect on
Src activation. We think that only the fraction of cortactin
that has translocated to the pedestals is available for serine
and tyrosine phosphorylation. These findings strongly
suggest a coordinated action of cortactin and N-WASP
during pedestal formation, consistent with the on/off
switching mechanism by which cortactin activates N-
WASP in vitro [14]. A remaining question is whether cort-
actin is phosphorylated sequentially, e.g. serine followed
by tyrosine phosphorylation. The lack of induction of
cortactin phosphorylation in N-WASP-deficient cells
should prove to be examined in many signaling transduc-
tion studies.
On the other hand, most studies have used inhibitors to
establish the role of kinases on pedestal signaling andCell Communication and Signaling 2009, 7:11 http://www.biosignaling.com/content/7/1/11
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have mainly focused on Tir phosphorylation [25]. To our
knowledge this is the first report that establishes the status
of Src activity during pedestal formation on N-WASP-defi-
cient cells. Another conclusion that can be drawn is that
Erk and Src kinases become activated in response to differ-
ent signals. Thus Src is not affected by ablation of N-WASP
whereas Erk activity is seriously compromised (Fig. 2). Erk
activation is shut off sooner in N-WASP-deficient cells
than in WT cells as seen in timing experiments. In con-
trast, the basal level of cortactin phosphorylated on serine
was higher in Nck-deficient cells than in WT cells, and it
was increased upon EPEC infection (data not shown).
Thus we can be confident that the lack of cortactin phos-
phorylation is not merely due to the lack of pedestals,
since cells deficient in either N-WASP or Nck do not form
pedestals [3,31].
We report here that cortactin and Tir bind each other
directly in vitro (Fig. 3A). Our initial hypothesis was that
they would interact directly through the SH3 domain cort-
actin, because Tir possess a consensus motif centered on
proline P20. Indeed, the SH3 domain was able to bind Tir,
but unexpectedly, the NH2 domain was also found to
bind Tir (Fig. 3). In addition, we did not detect differences
in the affinity binding of mutants that mimic phosphor-
ylation by Erk and Src, which contrast our previous bind-
ing studies in which a mutant that mimics
phosphorylation by Erk was found to bind preferentially
Model of cortactin action on EPEC pedestals Figure 5
Model of cortactin action on EPEC pedestals. (A) Model of coordinated action by cortactin and N-WASP on EPEC ped-
estals. In theory, cortactin may bind Tir and N-WASP simultaneously, via its N-terminal and SH3 domain interaction respec-
tively. EPEC-induced tyrosine phosphorylation of cortactin would terminate cortactin interaction with N-WASP but not with 
Tir. This could constitute a cyclical regulatory mechanism of actin polymerization on EPEC pedestals. Phosphotyrosine-cortac-
tin might as well compete for the SH2 domain of Nck, thus uncoupling Tir from the Nck/N-WASP complex. (B) In the absence 
of N-WASP protein, cortactin would only interact with Tir, which would not be sufficient for pedestal formation.Cell Communication and Signaling 2009, 7:11 http://www.biosignaling.com/content/7/1/11
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to N-WASP [14]. These results demonstrated that cortactin
and Tir interact directly in vitro, through both the N-termi-
nal region and the SH3 domain of cortactin, and this
interaction seems to occur independently of cortactin
phosphorylation. In agreement with this conclusion,
experiments using a two-hybrid system show that both
the N-terminal region and the SH3 domain of cortactin
bind TirEHEC. However, a major difference with our results
is that only tyrosine-phosphorylated cortactin bind TirE-
HEC, which contrasts with the transient phosphorylation
of cortactin induced by EHEC. Both findings were recon-
ciled by suggesting cortactin and Tir initially bind tran-
siently coincident with the tyrosine phosphorylation of
cortactin [26]. In our system, EPEC-infected cells still
showed high levels of N-WASP-dependent cortactin phos-
phorylation three hours after infection. These results high-
light the fine-tuned nature of cortactin regulation during
EPEC and EHEC infections.
Cortactin can activate the Arp2/3 complex directly
through its NTA domain [11,12], and indirectly by using
its SH3 domain to activate N-WASP [14]. We wondered
whether the binding of Tir to cortactin would activate the
latter and promote Arp2/3 complex-dependent actin
polymerization. As shown in Fig. 3B, Tir-coated beads
activated cortactin. Furthermore, as for the binding, the
activation of cortactin by Tir was not affected by the phos-
phorylation status of cortactin, which further supports the
idea that in EPEC signaling, Tir binds and activates cortac-
tin independently of the latter's phosphorylation status.
At this point, we favored the conclusion that the relevant
contribution underlying cortactin-Tir binding occurs
through the N-terminal moiety of cortactin, since our pre-
vious studies indicated that phosphorylation of cortactin
affects mainly its interaction with partners through the
SH3 domain [14]. To test this hypothesis, we used cell
lysates that represent a more restrictive scenario with
greater similarity to binding conditions in vivo. Consistent
with our reasoning, the N-terminal region of cortactin
bound Tir, whereas the isolated SH3 domain did not in
any of the cells type tested. In view of these results, we can
conclude that in cells cortactin binds Tir primarily
through its N-terminal region, while the contribution of
the SH3 domain seems to be irrelevant. Furthermore, the
interaction between Tir and cortactin is independent of
phosphorylation and does not require N-WASP, since we
detected similar levels of interaction in WT, N-WASP-defi-
cient and R cells.
Alternatively, the cortactin SH3 consensus site on Tir may
be occupied by other SH3 domains such as tyrosine
kinases [40] or the cortactin SH3-domain may have a pref-
erence for binding N-WASP. As previously described [14],
the SH3 domain of cortactin pulls down N-WASP. This
supports the idea that cortactin binds Tir through the N-
terminus and N-WASP through the SH3 domain. In this
case, phosphorylation should affect only the binding of
cortactin to N-WASP; in other words, cortactin phosphor-
ylated on serine would bind both Tir and N-WASP
whereas cortactin phosphorylated on tyrosine would bind
only Tir.
Both binding and activation experiments were also per-
formed with the Tir phosphorylation mimicking Y474D
mutant of Tir (data not shown). The fact that we did not
observe significant differences from WT Tir may means:
(i) the mutant does not behave like the phosphorylated
form or (ii) the binding and activation of cortactin is inde-
pendent of Tir phosphorylation on residue 474. Further
experiments are needed to address this question.
Finally, in our effort to understand what kind of com-
plexes form in vivo, we considered all available in vitro data
concerning the interaction of Tir, Nck, N-WASP and cort-
actin. Thus Nck binds cortactin only when phosphor-
ylated by Src [41], through an interaction between the
phosphotyrosine and the SH2 domain [42]. Therefore
since Tir and Nck interact through the single SH2 domain
of Nck, formation of a Tir-Nck-cortactin complex appears
to be impossible. Cortactin phosphorylated by Src is not
able to interact with N-WASP, as shown with recombinant
proteins [14] and further corroborated in the two-hybrid
assay [26]. That adds to the evidence against the possibil-
ity that cortactin bridges both proteins, i.e. Nck-cortactin-
N-WASP. This leaves three possible types of complexes: (i)
Tir-Nck-N-WASP-cortactin, (ii) Tir-cortactin-N-WASP and
(iii) Tir-cortactin. Given the fact that reducing of cortactin
expression with siRNA inhibits pedestal formation ([23]
and our unpublished results), that EPEC infection induces
cortactin phosphorylation in an N-WASP-dependent fash-
ion (Fig. 2), and that Tir binds and activates cortactin (Fig.
3) we conclude that cortactin contributes to the Tir-Nck-
N-WASP pathway, possibly by regulating N-WASP activ-
ity. In other words, cortactin and N-WASP would act in a
complex in this scenario. If we envision pedestals as a
dynamic actin structure, and in fact pedestal motility has
been shown [7], then it is reasonable to think that pro-
teins promoting actin polymerization would act in a cyclic
manner. We speculate that cortactin is a cycling switch for
N-WASP in pedestals (Model in Fig. 5).
Deletion of Tir abrogates pedestal formation by EPEC [24]
implying that Tir mediates the major but not only path-
way for actin assembly in pedestals. Indeed, elegant work
has shown that the EPEC effector protein EspF directly
activates N-WASP [43]. We can not exclude that cortactin
participates in this pathway.Cell Communication and Signaling 2009, 7:11 http://www.biosignaling.com/content/7/1/11
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Conclusion
The function of cortactin in pedestals, and how its func-
tion is regulated, seems to differ between EPEC and EHEC.
EHEC induces tyrosine dephosphorylation of cortactin
[26] whereas EPEC induces its tyrosine phophorylation
([26] and this study). During EHEC infection, the Tir-cort-
actin interaction was mapped to the N-terminal region of
both molecules, but only cortactin phosphorylated by Src
bound to TirEHEC.
In our study, cortactin bound directly to TirEPEC independ-
ently of phosphorylation since cortactin mutants mimick-
ing phosphorylation by Erk and Src interacted with Tir,
and were activated to a similar extent in vitro. This finding
further supports our results using EPEC-infected cells that
show that the interaction between Tir and cortactin is
mediated through the N-terminal part of the cortactin
molecule. Our results are compatible with the formation
of complexes in which cortactin may interact with Tir via
its N-terminal domain and with N-WASP via its SH3
domain. The later interaction would be terminated upon
tyrosine phosphorylation of cortactin (Model in Fig. 5).
Methods
Cells, bacteria, reagents and antibodies
HeLa human epithelial cells were obtained from ATCC
and grown in Iscove's Modified Dulbecco's Media
(IMDM) supplemented with 10% FBS (fetal bovine
serum). N-WASP-deficient and R mouse embryonic
fibroblasts (MEFs) were obtained from Dr. Scott Snapper
(Massachusetts General Hospital, Boston, USA) and
Nck1/2-deficient MEFs from Dr. Tony Pawson (Samuel
Lunenfeld Research Institute, Mount Sinai Hospital,
Toronto, Canada). Enteropathogenic Escherichia coli
(EPEC) E2348/69, as well as monoclonal antibodies
against the N- and C-termini Tir (2A5 and 2C3, respec-
tively) were provided by Dr. Brett B. Finlay (University of
British Columbia, Vancouver, Canada). Anti-N-WASP
antibody was previously described [44]. Commercial anti-
bodies used were: anti-cortactin 4F11 monoclonal anti-
body, anti-Src GD11 monoclonal and polyclonal anti-
phosphoY416 (activated Src) antibodies (Millipore), and
anti-actin C4 monoclonal antibody (MP Biomedical).
Anti-phospho-cortactin Y466 polyclonal antibody was
from Abcam (Cambridge, UK). Polyclonal anti-Erk1/2
(p44/42) and monoclonal anti-phospho-Erk (Thr202/
Tyr204, clone E10) antibodies were from Cell Signaling.
Anti-rabbit and anti-mouse horseradish peroxidase (HRP)
antibodies were from Amersham Pharmacia Biotech.
Cortactin and Tir constructs
Wild-type cortactin and selected mutants [14] were sub-
cloned in frame with GFP at the N-terminus in the plas-
mid pC2-EGFP (Invitrogen) and verified by sequencing.
The constructs used were full-length wild-type cortactin
(FL), and the following derivatives: the single point
mutants W22A and W525K; the double mutant
S405,418D; the triple mutant Y421,466,482D; an N-ter-
minal fragment of cortactin (NH2) containing residues 1–
333, and a cortactin fragment (residues 458–546) con-
taining the SH3 domain (SH3) aas. Two new mutants:
S405,418A and Y421,466,482F, were generated using
PCR and GST-FL as the template with the QuikChange
site-directed mutagenesis kit (Stratagene). The Tir Y474D
mutant was produced using the QuikChange kit.
Cell transfection, Western blotting and pedestal formation 
by EPEC
Cell transfection was carried out using Lipofectamine
2000 (Invitrogen). Briefly, HeLa cells were grown to 60–
70% confluence in 6-well plates. Transfections were incu-
bated for 16 hours in medium containing 10% FBS but no
antibiotics. Western blotting was done on cells from a sin-
gle well by directly adding 300 μl of 2× Laemmli buffer
and scraping the cells. Samples were homogenized by six
passages through a syringe with a 25-gauge needle, fol-
lowed by centrifugation at 21,000 g for 15 min at 4°C.
Samples were resolved by 10% SDS-PAGE and analyzed
by Western blotting and developed with ECL (Amer-
sham). Band densitometry was carried out using NIH
ImageJ software. Normalization for each experiment was
done by first, normalizing actin and next, the protein. The
average difference was calculated from three independent
experiments and reported as ± standard deviations.
EPEC infections were carried out as follows. Overnight
bacterial culture were grown at 37°C with shaking at 200
r.p.m., and 1 μl of culture was added per well of a 6-well-
plate. Pedestals were allowed to form for 3 hours in
medium containing 10% FBS and no antibiotics at 37°C
and 5% CO2. When indicated, EPEC was preactivated by
incubating a 1/100 dilution of the O/N culture for 2 hours
in medium containing 10% FBS and no antibiotics at
37°C and 5% CO2; the amount of bacteria from this pre-
activated culture that was added to wells was 1/8 that of
non-preactivated bacteria. Quantification was done by
counting the numbers of pedestals of attached bacteria for
a total of 100 cells. Experiments were performed at least
three times. Statistical analysis was carried out using Stu-
dent's t-test in Microsoft Excel.
Immunofluorescence microscopy and determination of 
total content of F-actin
Cells were fixed with 4% formalin solution (Sigma) at
room temperature and permeabilized with 0.1% Triton X-
100 for 5 min. After two washes with PBS, cells were
blocked with 2% BSA in PBS for 10 min and then sequen-
tially stained with 1 μg/ml tetramethyl rhodamine isotio-
cianate (TRITC)-phalloidin (Sigma) and DAPI (300 nM).
Photographs were taken using a Nikon Eclipse TE 200-UCell Communication and Signaling 2009, 7:11 http://www.biosignaling.com/content/7/1/11
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fluorescence microscope equipped with a Hamamatsu
camera. Images were processed with Adobe Phothoshop.
For determination of total content of F-actin, TRITC-phal-
loidin was used at 5 μg/ml. As a control, cells were pre-
treated 15 min with cytochalasin D at 2 μg/ml. Samples
were sorted by fluorescence using a FACS Scalibur station.
Experiments were performed at least three times. Statisti-
cal analysis was carried out using Student's t-test in Micro-
soft Excel.
Actin polymerization assays
GST recombinant proteins were produced, purified and,
when necessary, treated with PreScission protease accord-
ing to the manufacturer's recommendations (GE Health-
care) to remove GST. Carboxilate microspheres (1 μm;
Polysciences Inc.) were coupled to Tir/TirD in solution
(500 nM) and washed once with Xb buffer (10 mM
HEPES pH 7.8, 100 mM KCl, 0.1 mM CaCl2, 1 mM MgCl2,
1 mM ATP) and twice with Xb buffer-1% BSA to block
nonspecific interactions. Purified actin (2.5 μM) and Arp
(300 nM) were used. Cortactin and its mutants (500 nM)
were added to a final volume of 25 μl of Xb buffer. After 1
hour TRITC-phalloidin was added to a final concentration
of 3.3 μM. The solution containing the beads was placed
on a slide and sealed with paraffin. Pictures were acquired
while keeping all relevant parameters fixed (gain, expo-
sure time) to allow for fluorescence intensity comparison.
Experiments were performed at least three times.
Membrane enrichment procedure, pull-down experiments, 
and pervanadate treatment
After EPEC infection, MEFs were fractionated as described
[36] with some modifications. Briefly, MEFs were grown
to 70–80% confluence in 150-mm plates and infected
with preactivated EPEC. After 3 hours of infection, cells
were washed once with ice-cold PBS and rapidly lysed at
4°C by overlaying the cell monolayer for 10 min with 1
ml of buffer containing imidazole (pH 7.4), 250 mM
sucrose, protease-phosphatase inhibitor cocktail (Com-
plete™) and phosphatase inhibitor (PhosStop, Amer-
sham). Then the cells were collected using a cell scraper
(Sarstedt) and disrupted by six passages through a syringe
with a 25-gauge needle, followed by 15 min centrifuga-
tion at 3,000 g to remove cellular debris, bacteria and
nuclei. Clarified lysates were centrifuged again for 1 hour
at 21,000 g to separate the membrane (pellet) from the
cytoplasmic fraction (supernatant). Both of these final
fractions were stored at -70°C until further use.
For pull-down experiments pellets were resuspended in
400 μl of lysis buffer containing 0.1% Triton-X100, and a
fourth was used for each pull-down. GST, the GST-N ter-
minal (NH2) cortactin fragment and the GST-SH3 cortac-
tin domain were produced in BL21 E. coli, purified and
coupled to GSH-beads. Pull-downs were washed three
times with 100 μl of lysis buffer diluted 1:10 in PBS con-
taining 0.05% Tween 20.
Pull-down experiments with recombinant proteins were
performed as previously described [14]. When necessary
the GST was removed by Precission enzyme treatment
(Amersham).
Pervanadate treatment was carried out by mixing 1 mM of
NaVO4 with 1% H2O2 and diluting two-fold with IMDM
medium for 30 min at 37°C and 5% CO2.
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